Articles in section Research & Development
<< Opinion & Analysis | 447 articles | Royalties >> |
Pages 1 2 3 4 5 .. 45 | Next >> |
-
Boehringer Ingelheim Collaborates with Sosei Heptares for Antipsychotic Drugs
-
Gilead Collaborates with Merus For Novel Antibody-Based Trispecific T-Cell Engagers
-
Merck KGaA Pays C4 Therapeutics US$16 M Upfront for Protein Degraders
-
Novo Nordisk Signs US$252.6 M Deal with EraCal to Boost Obesity Portfolio
-
Roche Bolsters Pipeline with MediLink, Remix and MOMA Therapeutics Collaborations
-
Bristol Myers Squibb Signs Licensing Deal with Avidity Biosciences for Multiple Cardiovascular Targets
-
Merck & Co. Pays Daiichi Sankyo US$4 B Upfront for Cancer ADCs
-
Roche Signs US$2 B Partnership with Monte Rosa for Molecular Glue Medicines
-
Sanofi and Teva to Collaborate on Inflammatory Bowel Disease Treatment
-
Astellas Enters into Collaborations with PeptiDream and Cullgen to Advance Targeted Protein Degraders